hotspot -WSS

hotspot

author：Wikipedia 2025-09-27 12:36:34 - browse：9

Kevin Sayer, CEO of Dexcom Dexcom

For years, diabetes tech company Dexcom has been striving to get its continuous glucose monitors into the hands of type 2 diabetes patients. Last week at the American Diabetes Association’s conference, the company unveiled plans for software built entirely for these patients, including ones who don’t take insulin.

“We’ve been so focused on things that match the needs of somebody who manages diabetes every minute of every day, and insulin delivery,” Kevin Sayer, CEO of Dexcom, told STAT. “This new product is going to be designed to address the needs of somebody with diabetes who’s not doing that, who has type 2 diabetes and is on other drugs.”

Continuous glucose monitoring is already well-established among people with type 1 diabetes, who rely on constant insulin therapy. The technology, which helps patients noninvasively monitor their blood sugar levels and control their insulin pump in real time, has grown rapidly in use over the years, culminating in a $5 billion market.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

GET STARTED Log In

Previous article： 23andMe had bad news about my health. I wish a person had delivered it
Next article： STAT letters to the editor on burnt

entertainment

WSS

How Long Island became the ‘eugenics capital of the world’

Why more medical students aren't specializing in primary care

Americans' trust in science, scientist continues decline: Report

Why sickle cell disease is getting the first CRISPR treatment

What PEPFAR has meant on the ground in Ukraine

How to make Best Hospitals ratings actually useful for patients

leisure time

hotspot

hotspot

Medicare details structure of new drug price negotiation program

AstraZeneca bets AAV gene therapy will still deliver the goods

As demand for Covid shots wanes, Moderna seeks its next success

Appeals court upholds limits to abortion pill

FDA approval of Sarepta Duchenne genetic therapy gives me hope

Radiology is caught between AI's potential and concern for patients

Supreme Court strikes down use of affirmative action

Medicare explains how it will choose drugs for negotiation

As demand for Covid shots wanes, Moderna seeks its next success

Teach medical students about patients with intellectual disabilities

hotspot

Radiology is caught between AI's potential and concern for patients

STAT Health News: mRNA flu shots, Purdue SCOTUS case, etc

AstraZeneca bets AAV gene therapy will still deliver the goods

Why sickle cell disease is getting the first CRISPR treatment

After sickle

After sickle

hotspot

focus

entertainment

leisure time